Q3 2022 13F Holders as of 9/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Number of holders
-
30
-
Total 13F shares, excl. options
-
25.9M
-
Shares change
-
-606K
-
Total reported value, excl. options
-
$14.3M
-
Value change
-
-$392K
-
Number of buys
-
7
-
Number of sells
-
-12
-
Price
-
$0.55
Significant Holders of GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) as of Q3 2022
37 filings reported holding GLYC - GLYCOMIMETICS INC - Common Stock, par value $0.001 per share as of Q3 2022.
GLYCOMIMETICS INC - Common Stock, par value $0.001 per share (GLYC) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.9M shares
.
Largest 10 shareholders include BVF INC/IL (9.54M shares), NEA Management Company, LLC (9.09M shares), ACADIAN ASSET MANAGEMENT LLC (1.99M shares), VANGUARD GROUP INC (1.88M shares), BlackRock Inc. (766K shares), RENAISSANCE TECHNOLOGIES LLC (526K shares), MILLENNIUM MANAGEMENT LLC (366K shares), GEODE CAPITAL MANAGEMENT, LLC (358K shares), TWO SIGMA INVESTMENTS, LP (228K shares), and TWO SIGMA ADVISERS, LP (207K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.